HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shusaku Nakashima Selected Research

Rituximab (Mabthera)

1/2021Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shusaku Nakashima Research Topics

Disease

4Rheumatoid Arthritis
12/2021 - 09/2014
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 09/2020
3Premature Birth (Birth, Premature)
01/2022 - 05/2019
2Fever (Fevers)
01/2021 - 12/2020
1Rheumatic Diseases (Rheumatism)
07/2022
1COVID-19
07/2022
1Oral Ulcer (Mouth Ulcer)
01/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
09/2021
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
09/2021
1Disease Progression
01/2021
1Multi-centric Castleman's Disease
01/2021
1Ascites
01/2021
1Edema (Dropsy)
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Otitis Media
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Churg-Strauss Syndrome (Allergic Angiitis)
01/2021
1Renal Insufficiency (Renal Failure)
01/2021
1Nontuberculous Mycobacterium Infections
12/2020
1Nephritis
12/2020
1Communicable Diseases (Infectious Diseases)
12/2020
1Inflammation (Inflammations)
12/2020
1Infections
12/2020
1Glomerulonephritis
12/2020
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
12/2020
1Vasculitis (Vasculitides)
12/2020
1Endarteritis
12/2020
1Arthritis (Polyarthritis)
09/2020
1Dermatomyositis (Dermatopolymyositis)
08/2020
1Muscular Diseases (Myopathy)
08/2020
1Rupture
05/2019
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2015
1Lymphoma (Lymphomas)
03/2015
1Respiratory Insufficiency (Respiratory Failure)
01/2015

Drug/Important Bio-Agent (IBA)

3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2021
3CytokinesIBA
01/2022 - 01/2021
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 01/2015
2Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2021
2Immunoglobulin G (IgG)IBA
07/2022 - 12/2020
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2022 - 09/2020
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2022 - 01/2021
2tocilizumab (atlizumab)FDA Link
09/2021 - 01/2021
2Pharmaceutical PreparationsIBA
03/2015 - 09/2014
2Methotrexate (Mexate)FDA LinkGeneric
03/2015 - 09/2014
1Immunoglobulin M (IgM)IBA
07/2022
1RNA (Ribonucleic Acid)IBA
07/2022
1COVID-19 VaccinesIBA
07/2022
1mRNA VaccinesIBA
07/2022
1BNT162 VaccineIBA
07/2022
1SARS-CoV-2 spike proteinIBA
07/2022
1Messenger RNA (mRNA)IBA
07/2022
1GlucocorticoidsIBA
01/2022
1apremilastIBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1Abatacept (Orencia)FDA Link
12/2021
1mepolizumabIBA
01/2021
1Rituximab (Mabthera)FDA Link
01/2021
1InterleukinsIBA
01/2021
1Reticulin (Reticular Fiber)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1AntibodiesIBA
12/2020
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2020
1antiglomerular basement membrane antibodyIBA
12/2020
1Prednisolone (Predate)FDA LinkGeneric
10/2020
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2020
1EnzymesIBA
08/2020
1Biological ProductsIBA
05/2019
1Antirheumatic Agents (DMARD)IBA
05/2019

Therapy/Procedure

4Therapeutics
01/2022 - 01/2015